CDCP1 and lung adenocarcinoma: Awakura et al. [22] and Ikeda et al. [23] found that CDCP1 was highly expressed in renal cancer and lung adenocarcinoma, the expression of CDCP1 was significantly correlated with the development of the disease, and patients with high expression of CDCP1 had a lower overall survival rate.